PAX5 and breast cancer: Thus, we predicted the existence of CpG island of PAX5 promoter by Meth primer, and detected the methylation status of PAX5 in four subtypes of breast cells by BSP sequencing, which results showed the abnormal methylation of PAX5 in breast cancer.